Related Experiment Videos
Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex
J P Medema1, C Scaffidi, P H Krammer
1Tumor Immunology Program, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Abstract:
The Bcl-2 family member Bcl-xL has often been correlated with apoptosis resistance. We have shown recently that in peripheral human T cells resistance to CD95-mediated apoptosis is characterized by a lack of caspase-8 recruitment to the CD95 death-inducing signaling complex (DISC) and by increased expression of Bcl-xL (Peter, M. E., Kischkel, F. C., Scheuerpflug, C. G., Medema, J. P., Debatin, K.-M., and Krammer, P. H. (1997) Eur. J. Immunol. 27, 1207-1212). This raises the possibility that Bcl-xL directly prevents caspase-8 activation by the DISC. To test this hypothesis a cell line in which CD95 signaling was inhibited by overexpression of Bcl-xL was used. In these MCF7-Fas-bcl-xL cells Bcl-xL had no effect on the recruitment of caspase-8 to the DISC. It did not affect the activity of the DISC nor the generation of the caspase-8 active subunits p18 and p10. In contrast, cleavage of a typical substrate for caspase-3-like proteases, poly(ADP-ribose) polymerase, was inhibited in comparison with the control-transfected CD95-sensitive MCF7-Fas cells. To test whether Bcl-xL would inhibit active caspase-8 subunits in the cytoplasm, a number of immunoprecipitation experiments were performed. Using monoclonal antibodies directed against different domains of caspase-8, anti-Bcl-xL antibodies, or fusion proteins of glutathione S-transferase with different domains of caspase-8, no evidence for a direct or indirect physical interaction between caspase-8 and Bcl-xL was found. Moreover, overexpression of Bcl-xL did not inhibit the activity of the caspase-8 active subunits p18/p10. Therefore, in this cell line that has become resistant to CD95-induced apoptosis due to overexpression of Bcl-xL, Bcl-xL acts independently and downstream of caspase-8.
Insights
Bcl-xL overexpression confers resistance to CD95-mediated apoptosis by acting downstream of caspase-8 activation. This anti-apoptotic protein does not prevent caspase-8 recruitment or activity at the DISC, but inhibits downstream signaling.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Bcl-xL, a Bcl-2 family member, is linked to apoptosis resistance.
- Previous findings showed increased Bcl-xL expression in T cells resistant to CD95-mediated apoptosis.
- This suggested Bcl-xL might inhibit caspase-8 activation at the DISC.
Purpose of the Study:
- To investigate if Bcl-xL directly inhibits caspase-8 activation by the DISC.
- To determine the mechanism by which Bcl-xL confers resistance to CD95-induced apoptosis.
Main Methods:
- Utilized MCF7-Fas-bcl-xL cells overexpressing Bcl-xL to study CD95 signaling.
- Assessed caspase-8 recruitment to the DISC and its enzymatic activity.
- Performed immunoprecipitation assays to detect interactions between Bcl-xL and caspase-8.
- Monitored cleavage of caspase-3 substrates like poly(ADP-ribose) polymerase.
Main Results:
- Bcl-xL overexpression did not affect caspase-8 recruitment to the DISC or its activation.
- Cleavage of caspase-3 substrates was inhibited in Bcl-xL overexpressing cells.
- No physical interaction was detected between Bcl-xL and caspase-8.
- Bcl-xL did not inhibit the activity of active caspase-8 subunits.
Conclusions:
- In cells resistant to CD95-induced apoptosis due to Bcl-xL overexpression, Bcl-xL acts independently and downstream of caspase-8.
- Bcl-xL confers apoptosis resistance by inhibiting events subsequent to caspase-8 activation.